Itoh H, Shimono R, Murase K, Koito H, Iio A, Hamamoto K
Nihon Igaku Hoshasen Gakkai Zasshi. 1989 Jan 25;49(1):66-72.
This study reviewed 25 patients with the reflux sign in cholescintigraphy to assess its diagnostic value in evaluating biliary passage. After at least 4-hour fasting 5 mCi of 99mTcPMT or p-butyl IDA was injected intravenously and serial images were recorded before and after intramuscular injection of 10 micrograms of ceruletide diethylamine (caerulein). The reflux sign was determined positive when increased radioactivities in the left hepatic duct (minor reflux; MIR) or more peripheral intrahepatic ducts (major reflux; MAR) were recognized after injection of caerulein. The reflux sign was found in 28 of 237 (12%) studies. Direct and/or indirect X-ray cholangiograms were available in 25 (MIR; 15, MAR; 10). They included common bile duct (CBD) stone in 4, dilated CBD in 4, biliary dyskinesia (BD) in 4, chronic pancreatitis (CP) in 4, gallbladder (GB) stone in 3, duodenal ulcer (DU) in 2, CBD adenoma, pancreatic pseudocyst (PP), duodenal diverticle (DD), and acute cholangitis (AC) in 1 each. Their serum bilirubin levels were within normal limit in all but 2 at the time of cholescintigraphy. Transit time of radionuclides to the duodenum was found prolonged more than 60 min in 17 (68%) patients and persistent pooling in the CBD was found in 8 (28%) patients on scintigrams. The diameter of the CBD on X-ray cholangiogram was ranged 4 to 17 mm. Dilated CBD of more than 10 mm was found in 13 (52%) patients and apparent stenosis of the CBD in 6 (24%) patients. MAR seemed to correspond to increased diameter of the common hepatic more than 2 mm after caerulein injection in DIC. No abnormal findings in X-ray cholangiography was found in 10 (40%) patients including 3 with BD, 2 with GB stone, 2 with DU, 1 each with CP, PP, and AC. All those patients demonstrated MIR. We concluded that major reflux (MAR) sign was helpful in detecting an incomplete obstruction of the CBD, especially in patients with slightly to mildly dilated CBD.
本研究回顾了25例在肝胆闪烁显像中有反流征象的患者,以评估其在评估胆道方面的诊断价值。在至少禁食4小时后,静脉注射5mCi的99mTcPMT或对丁基IDA,并在肌肉注射10微克二乙胺缩胆囊素(胰泌素)前后记录系列图像。当注射胰泌素后左肝管(轻度反流;MIR)或更外周的肝内胆管(重度反流;MAR)放射性增加时,反流征象被判定为阳性。在237例研究中有28例(12%)发现了反流征象。25例(MIR;15例,MAR;10例)可获得直接和/或间接X线胆管造影。其中包括胆总管(CBD)结石4例、CBD扩张4例、胆道运动障碍(BD)4例、慢性胰腺炎(CP)4例、胆囊(GB)结石3例、十二指肠溃疡(DU)2例、CBD腺瘤、胰腺假性囊肿(PP)、十二指肠憩室(DD)各1例,急性胆管炎(AC)1例。除2例患者外,其余患者在进行肝胆闪烁显像时血清胆红素水平均在正常范围内。放射性核素到达十二指肠的通过时间在17例(68%)患者中延长超过60分钟,在闪烁图上8例(28%)患者的CBD中发现持续聚集。X线胆管造影显示CBD直径为4至17mm。13例(52%)患者的CBD扩张超过10mm,6例(24%)患者的CBD明显狭窄。在DIC中,MAR似乎与注射胰泌素后肝总管直径增加超过2mm相对应。10例(40%)患者在X线胆管造影中未发现异常,其中包括BD患者3例、GB结石患者2例、DU患者2例、CP、PP和AC患者各1例。所有这些患者均表现为MIR。我们得出结论,重度反流(MAR)征象有助于检测CBD的不完全梗阻,尤其是在CBD轻度至中度扩张的患者中。